Stay updated on Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial

Sign up to get notified when there's something new on the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The clinical-trial record is now displayed, including the study design, eligibility criteria, treatment arms, outcome measures, and record dates. The study is marked completed and no longer recruiting.
    Difference
    52%
    Check dated 2026-11-07T12:20:14.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T12:54:17.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces website transition updates and says NIH content may use “Super Intelligence” in place of “Artificial Intelligence.” No clinical-trial details are provided.
    Difference
    1%
    Check dated 2026-10-24T14:35:23.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:27:56.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:33:50.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previous study content with an access-restricted message. The layout remains with header and footer visible, indicating the record is currently inaccessible.
    Difference
    18%
    Check dated 2026-09-19T18:46:53.000Z thumbnail image

Stay in the know with updates to Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page.